U.S. markets closed

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.58-1.17 (-2.94%)
At close: 4:00PM EST

38.58 0.00 (0.00%)
After hours: 4:20PM EST

Sign in to post a message.
  • t
    toostsie
    PT=$60 Insmed to Present at the Evercore ISI 3rd Annual HealthCONx Conference
    that management will present at the virtual Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 8:00 a.m. ET.=Firesidechat
  • K
    Kinky
    Here's your chart! | Market cap vs GDP = 179% the highest in History! \ Dont worry! | It means nothing! \
  • s
    shimantokawa
    Ouch again. On 11/13 the shorts had increased 600k shares and it closed at $36.14. Now that we are at nearly 40 bucks, did the shorts cover slightly or did they dig in deeper? Hmmm
  • J
    Jan
    Oncoinnune acquired by Merck. cuts hospitalizations time in hospital for patients requiring ventilators for 425 Million
    425 Million
  • T
    Terry
    Investor village we know is not rational investing.
    ei: A post announced that " Arikayce Launch EU, going fast now!... 24 languages ! " The .PDF file is from the EUs informational site.
    The reality with the Launch is.....the launch will go slow. Insmed plans a single country (Germany) launch early next year, hopefully followed by the United Kingdom, but its individual country's coverage that will dictate the pace of the launch. I've been here before.
    Informed Insmed investors know the French example ( not the coverage,because the CC program allowed top dollar) but the amount of acceptance.
    Arikayce will find limited use as a last resort therapy,used with additional anti-biotics as it has in the U.S. It will take years to reach full market penetration in the EU (above stated reason) and revenues will pale those of the U.S. I steer clear investors of IV's misdirection. Shareholders have good reason to be optimistic about Insmed but Arikaayce is currently not the focal point of Insmed's interest. Good Luck
    Bullish
  • r
    rufus
    Insmed needs News
    ISIEvercore $60 target and another Zoom chat aint going to do it. Covid trial will
  • C
    Cindy
    The stock market hit 30,000 today because we’re getting a new president
    COVID-19 deaths hit 260,000 today because we never had one.
    jmho
  • r
    rocky
    According to Yahoo! INSM is overvalued at 3.75B with 168.M in sales.
    So how would a suitor value Brensocatib? Bio index flat with all the vaccine news?
    Have we reached a top? An offering now will seal the deal for months of nothing. Reality check. The Brensocatib covid trial results will now be out after a vaccine is on the market.
    Insmed is the Carolina Panthers of bio- always find a way to lose
  • J
    Joseph
    Chalmers states the end of recruitment and results are really
    Close!? Didn’t they just recruit their 200th patient?
  • a
    al
    Insmed Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
    looks like the trial didnt start Nov1 " Insmed plans to initiate the registrational Phase 3 ASPEN trial of brensocatib in patients with NCFBE by the end of 2020."
  • h
    hundred
    Is Morgan Stanley fighting with Credit Suisse for the next offering? "INSM Target Raised by Morgan Stanley with price target $38.00 ➝ $42.00 and rating Overweight"
    May 22, 2019 — Morgan Stanley & Co. LLC, SVB Leerink LLC and Goldman Sachs & Co. LLC are acting as joint book-running managers for the offering. Leerick News soon !
  • M
    Mormon
    Pfizers Phaselll results just out. Forget about the stop covid Insmed trial. Too late.
    Pfizer expects to submit "in a matter of days" for approval Vaccine initial mfg to healthcare workers .
    By summer many should be vaccinated. BUT this winter will be rough so wear a mask and stay away from crowds.
  • J
    Jan
    On Fri CEO Lewis and Ch legal officer exercised their options and purchased more stock.
    Insmed's Chair&Chief Executive Officer just picked up 28,639 shares. Lewis now owns 164,787 shares of the company.
  • K
    Kinky
    Hope the DonJR makes it,not like thatloser Hermain Cain!\ I like my covid patients that dont die\ Did DonJr get the covid from Melania?? \ I dont know if it's true but we should really look into what their relationship has been! \ Hope this European trial news comes out soon.
  • m
    maria
    Professor James D Chalmers takes a stand against the Trumpanti - science adgenda
    "This is an important, well written, and powerful article at bmj_latest
    "The suppression of science during the pandemic is real and has happened at all levels.
  • M
    Mormon
    So needed "Biden’s Transition Teams Suggest Tougher Wall Street Oversight "
    Start with not allowing INSM shares to be simultaneously shorted against offering shares.
  • Y
    Yous
    Pump and dump? at least once a year INSM does this. look back to a double in Jan 19 etc.
    The volume has been very average for a 30% move.
  • Y
    Yahoo Finance Insights
    Insmed reached a 52 Week high at 40.00
  • J
    Jan
    Enjoy your posts but the investor village thing is unnecessary. Anyone accessing these boards has given the village a look and Stock pumping is all one sees. imo A takeover is the plan. I do not think big money will wait years.
  • m
    maria
    Professor Chalmers says 200 have been enrolled now. Insmed has said nothing about the trials progress.
    Interim analysis was not done at 100 patients as had been hoped for, [ala todays Pfizer trial] which means the results have been inconclusive so far. so 300 patients are needed and are being enrolled.
    Professor Chalmers says next year. Insmed has said nothing about the trials progress.
    Rockys point about a vaccine before the stop covid trial results now is a far cry from last APRIL.